circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis.

Zhou, Zhigang; Qin, Jing; Song, Cailu; Wu, Tao; Quan, Qiang; Zhang, Yan; Zou, Yani; Liu, Lingrui; Tang, Hailin; Zhao, Jianfu.

Afiliação

Zhou Z; Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
Qin J; Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415003, China.
Song C; Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415003, China.
Wu T; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Quan Q; Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415003, China.
Zhang Y; Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
Zou Y; Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
Liu L; Research Center of Cancer Diagnosis and Therapy, Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.
Tang H; The First People's Hospital of Fuyang City, Fuyang, 236012, China.
Zhao J; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.